Full-Time

Program Manager 1/2

Posted on 10/4/2025

Curia

Curia

1,001-5,000 employees

End-to-end drug development and manufacturing

Compensation Overview

$54k - $90.9k/yr

Albany, NY, USA

Hybrid

Hybrid position with in-office presence required in Albany, NY.

Category
Business & Strategy (1)
Required Skills
Marketing
Data Analysis
Requirements
  • Minimum Bachelor’s Degree in Business, Marketing or Science related field
  • Proficient in MS Office, 365 preferred
Responsibilities
  • Solicit and objectively consider input from team members with differing perspectives on the project. Display respect and appreciation for individual differences; values the contributions of others
  • Readily cooperate, share information, and provide suggestions to meet team goals
  • Volunteer for, and commit to, assignment necessary to achieve team goals
  • Understand job duties and responsibilities and take accountability for accomplishing objectives. Seek clarification when necessary to ensure personal performance aligns with expectations
  • Strive to deliver measurable results and take initiative to improve performance when it deviated from standards
  • Learn to anticipate potential challenges in own work and develop personal strategies to overcome them
  • Identify who customers are and begin to develop rapport and relationships with them
  • Gain an understanding of customers’ needs and perceptions by listening directly to them or utilizing colleagues’ relationships. Learn to recognize when customers are dissatisfied and assist in resolving issues in a mutually beneficial manner. Follow up promptly with customers to ensure that needs have been addressed
  • Communicate ideas clearly with an appropriate level of detail and listen for input to identify key concerns. Listen carefully, asking questions and paraphrasing statements to ensure understanding. Respond to objections with supporting data and information
  • Paraphrase others’ points of view to check for understanding and communicate areas of agreement
  • Gather information from multiple sources to support management and team in creating/adjusting project plans
  • Test, monitor and review the implemented solution; communicate findings to appropriate parties
  • Attend to messages from others; correctly interpret messages and respond appropriately
  • Raise issues in a courteous manner, referring to manager for guidance in sensitive situations
  • Contribute to idea generation and solution development for simple problems. Analyze ideas and solutions and provide data to support implementation. Suggest new ways to apply existing knowledge
Desired Qualifications
  • PMP certification

Curia is a contract development and manufacturing organization (CDMO) that partners with pharmaceutical and biotech companies to move medical breakthroughs from concept to market. It provides end-to-end services across the drug development lifecycle, including early research, method development and validation, preformulation, material science, solid-state chemistry, and package device testing. Revenue comes from service contracts for specialized capabilities and expertise, with clients ranging from small startups to large pharma. Curia also collaborates with industry leaders to advance continuous flow development and manufacturing programs. The company differentiates itself through flexible and scalable solutions, deep scientific expertise, and state-of-the-art technology that help clients accelerate development timelines while navigating discovery to commercialization. Its goal is to enable efficient, reliable progression of drug candidates from conception through to market approval.

Company Size

1,001-5,000

Company Stage

Debt Financing

Total Funding

$1.1B

Headquarters

Albany, New York

Founded

1991

Simplify Jobs

Simplify's Take

What believers are saying

  • Biologics segment expansion under Steve Lavezoli accelerates high-margin pharmaceutical outsourcing revenue growth.
  • Carterra partnership positions Curia to capture Pacific Northwest biotech demand in antibody discovery services.
  • Gerald Auer's CFO appointment signals M&A activity and potential strategic initiatives enhancing shareholder value.

What critics are saying

  • Pace Life Sciences acquisition of New Jersey lab erodes Curia's analytical testing capacity and revenue.
  • Larger CDMOs like Lonza and Catalent undercut Curia on biologics capacity, stealing biotech contracts.
  • FDA scrutiny on srRNA manufacturing defects from Replicate Bioscience Phase 1 triggers potential client exodus.

What makes Curia unique

  • Pioneer in self-replicating RNA manufacturing, demonstrated through Replicate Bioscience Phase 1 clinical trial support.
  • Integrated enzymatic doggybone DNA technology via Touchlight collaboration expands mRNA manufacturing competitive advantages.
  • End-to-end CDMO services from discovery through cGMP manufacturing differentiate Curia from specialized competitors.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid Vacation

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
The Carlyle Group
Jan 30th, 2026
AMRI Announces Completion of Acquisition by The Carlyle Group and GTCR | Carlyle

ALBANY, N.Y. – Albany Molecular Research, Inc. (NASDAQ:AMRI), a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, today announced the completion of its previously announced acquisition by affiliates of The Carlyle Group (“Carlyle”) and affiliates of GTCR LLC (“GTCR”). President and Chief Executive Officer William S. Marth will continue to lead AMRI.

BERNAMA
May 10th, 2024
BIOLOGICS SYMPOSIUM: CURIA, CARTERRA PARTNER TO ADVANCE BIOTECH RESEARCH IN PACIFIC NORTHWEST

KUALA LUMPUR, May 10 (Bernama) - Curia, a contract research, development and manufacturing organisation (CDMO) has announced a partnership with Carterra Inc in hosting a high-throughput biologics symposium slated for May 31, in Seattle, Washington.

PharmiWeb.com
Mar 14th, 2024
Pace® Life Sciences Acquires New Jersey Laboratory From Curia

Former Whitehouse Analytical Laboratory is Now Part of the Pace® Laboratory Network

PPI News Agency
Feb 23rd, 2024
Curia Appoints Steve Lavezoli as Vice President, Biologics

ALBANY, N.Y., Feb. 23, 2024 (GLOBE NEWSWIRE) - Curia, a leading contract research, development and manufacturing organization, today announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26.

Cameroon Online News
Feb 5th, 2024
Curia Receives 2024 CDMO Leadership Award

Curia was awarded based on the feedback of respondents in the Small Pharma category.

INACTIVE